YPEL3, a p53-regulated gene that induces cellular senescence
Kevin D Kelley1, Kelly R Miller, Amber Todd
1Biochemistry & Molecular Biology Department, Wright State University, Dayton, Ohio 45435, USA.
Abstract:
Cellular senescence, the limited ability of cultured normal cells to divide, can result from cellular damage triggered through oncogene activation (premature senescence) or the loss of telomeres following successive rounds of DNA replication (replicative senescence). Although both processes require a functional p53 signaling pathway, relevant downstream p53 targets have been difficult to identify. Discovery of senescence activators is important because induction of tumor cell senescence may represent a therapeutic approach for the treatment of cancer. In microarray studies in which p53 was reactivated in MCF7 cells, we discovered that Yippee-like-3 (YPEL3), a member of a recently discovered family of putative zinc finger motif coding genes consisting of YPEL1-5, is a p53-regulated gene. YPEL3 expression induced by DNA damage leads to p53 recruitment to a cis-acting DNA response element located near the human YPEL3 promoter. Physiologic induction of YPEL3 results in a substantial decrease in cell viability associated with an increase in cellular senescence. Through the use of RNAi and H-ras induction of cellular senescence, we show that YPEL3 activates cellular senescence downstream of p53. Consistent with its growth suppressive activity, YPEL3 gene expression is repressed in ovarian tumor samples. One mechanism of YPEL3 downregulation in ovarian tumor cell lines seems to be hypermethylation of a CpG island upstream of the YPEL3 promoter. We believe these findings point to YPEL3 being a novel tumor suppressor, which upon induction triggers a permanent growth arrest in human tumor and normal cells.
Insights
Yippee-like-3 (YPEL3) is a novel tumor suppressor gene. Its activation by DNA damage induces cellular senescence, a permanent growth arrest, and is repressed in ovarian tumors, suggesting a therapeutic target for cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Cellular senescence limits normal cell division and can be triggered by oncogene activation or telomere loss.
- The p53 signaling pathway is crucial for senescence, but its downstream targets remain largely unidentified.
- Inducing tumor cell senescence is a potential cancer therapeutic strategy.
Purpose of the Study:
- To identify novel p53-regulated genes involved in cellular senescence.
- To investigate the role of Yippee-like-3 (YPEL3) in p53-mediated senescence.
- To explore YPEL3's potential as a tumor suppressor.
Main Methods:
- Microarray analysis to identify p53-regulated genes in MCF7 cells.
- Investigated p53 recruitment to the YPEL3 promoter.
- Utilized RNA interference (RNAi) and H-ras induction to study YPEL3's function in senescence.
- Analyzed YPEL3 expression in ovarian tumor samples and methylation status.
Main Results:
- Yippee-like-3 (YPEL3) was identified as a p53-regulated gene.
- YPEL3 induction by DNA damage leads to p53 recruitment and increased cellular senescence.
- YPEL3 activates cellular senescence downstream of p53.
- YPEL3 expression is downregulated in ovarian tumors, potentially via promoter hypermethylation.
Conclusions:
- YPEL3 acts as a novel tumor suppressor by inducing permanent cell growth arrest (senescence).
- YPEL3's function is downstream of p53 and is repressed in ovarian cancer.
- YPEL3 represents a potential therapeutic target for cancer treatment by reactivating senescence.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Replicative Cell Senescence
Replicative Cell Senescence
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle

